Serum Acylcarnitines and Risk of Cardiovascular Death and Acute Myocardial Infarction in Patients With Stable Angina Pectoris [Preventive Cardiology]

ConclusionsAmong patients with suspected stable angina pectoris, elevated serum even‐chained acylcarnitines were associated with increased risk of cardiovascular death and, to a lesser degree with acute myocardial infarction, independent of traditional risk factors.Clinical Trial RegistrationURL: http://www.clinicaltrials.gov. Unique identifier: NCT00354081.

Source: JAHA:Journal of the American Heart Association - February 3, 2017 Category: Cardiology Authors: Strand, E., Pedersen, E. R., Svingen, G. F. T., Olsen, T., Bȷorndal, B., Karlsson, T., Dierkes, J., Nȷolstad, P. R., Mellgren, G., Tell, G. S., Berge, R. K., Svardal, A., Nygard, O. Tags: Biomarkers, Risk Factors, Myocardial Infarction, Mortality/Survival, Vascular Disease Original Research Source Type: research